NTAP vs RARE · P/E 28, rev $6.24B vs rev $350.0M
NetApp Inc (NTAP) versus Ultragenyx (RARE) — a side-by-side from cached financials, not a winner call.
NetApp Inc (NTAP) is a software - infrastructure company listed on US.
Ultragenyx (RARE) is a biotechnology company listed on US.
Latest reported NTAP revenue for 2026-04-24 was $6.24B. Net income was $1.28B. Revenue was down 5.1% from 2025-04-25 to 2026-04-24. NTAP currently screens at market cap $35.43B and trailing P/E 28.2.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
NTAP currently screens at market cap $35.43B and trailing P/E 28.2. RARE currently screens at market cap $2.79B.
Not investment advice. Open the NTAP and RARE stock pages for the full models.
Not investment advice.